Generic Medicine Info
Indications and Dosage
Fever, Mild to moderate pain
Adult: 33-50 kg: 15 mg/kg 4-6 hourly if needed. Max: 3 g daily. >50 kg: 1 g 4-6 hourly if needed. Max: 4 g daily. Administer by infusion over 15 minutes.
Child: Full-term neonates and children <10 kg: 7.5 mg/kg as a single dose, at least 4 hourly. Max: 30 mg/kg/day; 10-33 kg: 15 mg/kg as a single dose, at least 4 hourly. Max: 2 g daily; 33-50 kg: 15 mg/kg as a single dose, at least 4 hourly. Max: 3 g daily; >50 kg: Same as adult dose.

Post-immunisation pyrexia
Child: 2-3 months 60 mg as a single dose. May give 2nd dose after 4-6 hours if needed. Max: 4 doses daily.

Fever, Mild to moderate pain
Adult: 0.5-1 g 4-6 hourly. Max: 4 g daily.
Child: 1-2 months 30-60 mg 8 hourly. Max: 60 mg/kg/day; 3-<6 months 60 mg. 6 months to <2 years 120 mg; 2-<4 years 180 mg; 4-<6 years 240 mg; 6-<8 years 240 or 250 mg; 8-<10 years 360 or 375 mg; 10-<12 years 480 or 500 mg; 12-16 years 480 or 750mg. Administer 4-6 hourly if necessary. Max: 4 doses in 24 hours.

Fever, Mild to moderate pain
Adult: As supp: 0.5-1 g 4-6 hourly. Max: 4 g daily.
Child: 3 months to <1 year 60-125 mg; 1-<5 years 125-250 mg: 5-<12 years 250-500 mg; 12-17 years 500 mg. Given 4-6 hourly if needed. Max: 4 doses/day.

Post-immunisation pyrexia
Child: 2-3 months 60 mg as a single dose. May give 2nd dose after 4-6 hours if needed.
Renal Impairment
CrCl (mL/min) Dosage
<30 Increase dosing interval to 6 hrly. Max: 3 g daily.
Hepatic Impairment
Mild to moderate pain; Fever: Dosage reduction may be needed. Recommendation: Max: ≤2-3 g daily.
Mild or moderate: Max: 3 g daily. Severe: Contraindicated.
May be taken with or without food.
IV: Dilute with NaCl 0.9% or glucose 5% to make a concentration of not less than 1 mg/mL.
Incompatible with acyclovir Na, diazepam, chlorpromazine HCl.
Hypersensitivity. Severe hepatic impairment or active liver disease (IV).
Special Precautions
Patient with known G6PD deficiency, alcohol dependence, chronic malnutrition or dehydration, weight <50 kg; severe hypovolaemia (IV). Renal and hepatic impairment. Children. Pregnancy and lactation.
Adverse Reactions
Significant: Thrombocytopenia, leucopenia, neutropenia, pancytopenia, methaemoglobinaemia, agranulocytosis, angioedema, pain and burning sensation at inj site. Rarely, hypotension and tachycardia.
Gastrointestinal disorders: Nausea, vomiting, constipation.
Nervous system disorders: Headache.
Psychiatric disorders: Insomnia.
Skin and subcutaneous tissue disorders: Erythema, flushing, pruritus.
Potentially Fatal: Hepatotoxicity, acute renal tubular necrosis. Rarely, hypersensitivity reactions such as acute generalised exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN).
PO/Rectal: B; IV/Parenteral: C
Monitoring Parameters
Assess patient for history of liver disease or alcohol abuse.
Symptoms: Pallor, nausea, vomiting, anorexia, abdominal pain, metabolic acidosis, glucose metabolism abnormalities. After 12-48 hours of ingestion, liver damage may become apparent, which may lead to encephalopathy, haemorrhage, hypoglycaemia, hypotension, cerebral oedema, cardiac arrhythmia, and pancreatitis. Management: Administer activated charcoal within 1 hour of ingestion. Determine plasma paracetamol concentration ≥4 hours after ingestion. IV N-acetylcysteine may be used up to 24 hours after ingestion (most effective if given within 8 hours). As an alternative, oral methionine can also be used if vomiting is not a problem.
Drug Interactions
Decreased absorption with colestyramine. Decreased serum concentrations with rifampicin and some anticonvulsants (e.g. phenytoin, phenobarbital, carbamazepine, primidone). Enhances the anticoagulant effect of warfarin and other coumarins with prolonged use. Increased absorption with metoclopramide and domperidone. Increased serum concentration with probenecid. May increase serum concentration of chloramphenicol.
Food Interaction
Increased risk of hepatotoxicity with alcohol. Decreased serum concentration with St John’s wort.
Lab Interference
May produce false-positive test results for urinary 5-hydroxyindoleacetic acid.
Description: Paracetamol exhibits analgesic action by peripheral blockage of pain impulse generation. It produces antipyresis by inhibiting the hypothalamic heat-regulating centre. Its weak anti-inflammatory activity is related to inhibition of prostaglandin synthesis in the CNS.
Synonym: acetaminophen.
Onset: Oral: <1 hour. IV: 5-10 minutes (analgesia); within 30 minutes (antipyretic).
Duration: Oral, IV: 4-6 hours (analgesia). IV: ≥6 hours (antipyretic).
Absorption: Well absorbed after oral and rectal administration. Time to peak plasma concentration: Approx 10-60 minutes (oral); 15 minutes (IV); approx 2-3 hours (rectal).
Distribution: Distributed into most body tissues. Crosses placenta and enters breast milk. Plasma protein binding: Approx 10-25%.
Metabolism: Mainly metabolised in the liver via glucuronic and sulfuric acid conjugation. N-acetyl-p-benzoquinone imine (NAPQI), a minor metabolite produced by CYP2E1 and CYP3A4, is further metabolised via conjugation with glutathione in the liver and kidneys.
Excretion: Mainly via urine (<5% as unchanged drug; 60-80% as glucuronide metabolites and 20-30% as sulphate metabolites). Elimination half-life: Approx 1-3 hours.
Chemical Structure

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Acetaminophen, CID=1983, (accessed on Jan. 22, 2020)

Tab/cap/susp/solution: Store between 20-25°C. Do not freeze. Protect from light and moisture. Rectal Supp: Store between 2-25°C. Do not freeze.
MIMS Class
Analgesics (Non-Opioid) & Antipyretics
Acetaminophen Capsules 325mg (Humanwell PuraCap Pharmaceutical Co., Ltd). DailyMed. Source: U.S. National Library of Medicine. Accessed 21/06/2018 .

Acetaminophen: Drug Safety Communication-Association with Risk of Serious Skin Reactions. U.S. FDA. Accessed 24/07/2014.

Alvedon Suppositories 125 mg (Intrapharm Laboratories Limited). eMC. Accessed 20/06/2018.

Alvedon Suppositories 60, 125, 250 mg (AstraZeneca UK Limited). eMC. Accessed 24/07/2014.

Anadin Paracetamol Tablets (Pfizer Consumer Healthcare). eMC. Accessed 20/06/2018.

Anon. Acetaminophen. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. Accessed 20/06/2018.

Anon. Acetaminophen. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 20/06/2018.

Buckingham R (ed). Paracetamol. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 20/06/2018.

Children’s Tylenol (Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division). DailyMed. Source: U.S. National Library of Medicine. Accessed 21/06/2018.

Joint Formulary Committee. Paracetamol (Acetaminophen). British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 20/06/2018.

Perfalgan 10 mg/mL Solution for Infusion (Bristol-Myers Squibb Pharmaceuticals Limited). eMC. Accessed 21/06/2018 .

Disclaimer: This information is independently developed by MIMS based on Paracetamol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
  • Acet
  • Aeknol
  • Aizet-S
  • Baropyrine
  • Biocet
  • Biogesic FastFizz
  • Biopain
  • Bioretic
  • Cetamin
  • Clocephen
  • Cloxina
  • Corgic/Corgic Plus
  • Cortalgesic Xtra
  • Detramol
  • Dolonil
  • Eurogesic
  • Fastamol
  • Fevercare
  • Infulgan
  • Isoflu (Combipack)
  • Lafayette Paracetamol
  • Lexalgin
  • Medgenol
  • Myremol
  • Nahalgesic
  • Napalgin
  • Naprex
  • Oxydol
  • Panadene
  • Panadol
  • Para-4-Kids
  • Paracef
  • Paramed
  • Parvid
  • Poro
  • PRC Suspension/PRC Drops
  • PRC Tablet
  • Pyreset
  • Pyritas
  • Rapidol
  • Raxem
  • Rexidol
  • Riber
  • Rongesic
  • Selegesic
  • Sinomol
  • Sintos
  • Tempcaire
  • Teramol/Teramol Forte
  • TGP Paracetamol
  • Tylenol
  • Ultragesic
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in